Skip to main content
logo
Nextage Therapeutics Ltd (TLV:NXTG)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
36.10
-0.70 (-1.90%)
Oct 13, 2026, 5:24 PM IDT

Nextage Therapeutics Ratios and Metrics

Millions ILS. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
292624---
Market Cap Growth
11.48%10.48%----
Enterprise Value
362624---
Last Close Price
0.360.780.790.340.582.21

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
11.657.307.37---
PB Ratio
1.261.89-1.18---
P/FCF Ratio
--36.61---
P/OCF Ratio
--36.61---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
14.497.287.43---
EV/FCF Ratio
--36.90---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.331.25-0.60-0.14-0.78-
Debt / FCF Ratio
--18.55---
Net Debt / Equity Ratio
0.331.23-0.600.041.87-
Net Debt / EBITDA Ratio
-0.64-2.23-2.330.030.14-
Net Debt / FCF Ratio
-0.72-2.6218.530.030.13-
Asset Turnover
0.060.141.435.85--
Quick Ratio
0.060.060.030.240.75-
Current Ratio
0.060.060.030.240.80-
Return on Assets (ROA)
-16.74%-20.55%-151.53%-255.08%--
Return on Capital Employed (ROCE)
-46.90%-46.80%31.70%202.20%2248.10%-

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-54.14%-23.09%-37.12%---
FCF Yield
-36.12%-24.80%2.73%---
Buyback Yield / Dilution
-97.94%19.42%-77.80%-4.79%-6.98%-127.75%